AEON Biopharma, Inc. — Investor Relations & Filings
Filings indexed
317
across all filing types
Latest filing
2026-05-14
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
AEON
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company focused exclusively on developing therapeutic applications for botulinum toxins. The company is advancing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA), for the treatment of debilitating nervous system-related and neuromuscular disorders. Its lead clinical programs are investigating ABP-450 for the prevention of chronic and episodic migraines and the treatment of cervical dystonia. By concentrating solely on therapeutic indications, AEON aims to unlock the full potential of neurotoxins to provide lasting relief for patients with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | |
| DEF 14A - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | |
| 4 - AEON BIOPHARMA, INC. (0001837607) (Filer) | 2026-02-20 | English | |
| 424B3 Filing | 2026-02-18 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 46344664 | 10-Q | 2026-05-14 | English | ||
| 46257361 | 8-K | 2026-05-14 | English | ||
| 38833816 | ARS - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | ||
| 38832256 | DEF 14A - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | ||
| 32899519 | 4 - AEON BIOPHARMA, INC. (0001837607) (Filer) | 2026-02-20 | English | ||
| 32002100 | 424B3 Filing | 2026-02-18 | English | ||
| 18394499 | S-3 - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-02-09 | English | ||
| 32002215 | SCHEDULE 13D/A Filing | 2026-01-29 | English | ||
| 32002182 | 3 Filing | 2026-01-29 | English | ||
| 32002083 | SCHEDULE 13D Filing | 2026-01-29 | English | ||
| 13355752 | 8-K | 2026-01-21 | English | ||
| 13355753 | 8-K | 2026-01-12 | English | ||
|
2025
3 filings
| |||||
| 13355754 | DEF 14A | 2025-12-29 | English | ||
| 13355756 | PRE 14A | 2025-12-19 | English | ||
| 13355755 | 8-K | 2025-12-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
|
Bioceltix S.A.
Develops stem cell-based medicinal products for veterinary …
|
BCX | PL | Manufacturing |
|
BioChem Pharma Inc.
Produces and commercializes high-quality pharmaceuticals, f…
|
— | CA | Manufacturing |
|
Biocon Ltd.
Develops biosimilars and novel biologics for diabetes, onco…
|
BIOCON | IN | Manufacturing |
AEON Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35234/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35234 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35234 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35234 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35234}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AEON Biopharma, Inc. (id: 35234)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.